1-3 of 3
Chin Pan
Close
Sort by
Journal Articles

Abbv-101, a Highly Potent and Selective Clinical Stage Bruton Tyrosine Kinase Degrader for the Treatment of B-Cell Malignancies

Chin Pan, Tarikere L Gururaja, Haiyan Li, Henry Nguyen, Yongjiao Zhai, Xiaoping Xie, Rong-Xian Ding, Rebecca Mathew, Hana Y Hoh, Zhaozhong J Jia, Bo Liu, Cassandra Shu, Wissam Assaily, Lloyd T Lam, Jacob J Riehm, Claudina Stevenson, Christine Will, Federico Innocenti, Alexey Rivkin
Journal: Blood
Blood (2023) 142 (Supplement 1): 1887.
https://doi.org/10.1182/blood-2023-184835
Published: 2023
Journal Articles

BMS-936564/MDX-1338: A Fully Human Anti-CXCR4 Antibody Induces Apoptosis In Vitro and Shows Anti Tumor Activity In Vivo

Michelle R. Kuhne, PhD, Tanya Mulvey, Sharline Chen, Chin Pan, Ph.D., Colin Chong, Wafa Niekro, Tom Kempe, Ph.D., Karla A. Henning, Ph.D., Lewis Cohen, MD, MS, Alan Korman, Ph.D., Pina M Cardarelli, Ph.D.
Journal: Blood
Blood (2011) 118 (21): 1543.
https://doi.org/10.1182/blood.V118.21.1543.1543
Published: 2011
Journal Articles

The New CXCR4 Inhibitor MDX-1338 Exerts Anti-Tumor Activity in Multiple Myeloma

Aldo M Roccaro, MD, PhD, Antonio Sacco, BS, Michelle Kuhne, PhD, AbdelKareem Azab, PhD, Patricia Maiso, PhD, Yong Zhang, PhD, Yang Liu, PhD, Feda Azab, BPharm, Ghayas C Issa, MD, Phong Quang, BS, Hai T Ngo, BS, Chin Pan, Ph.D., Lew Choen, PhD, Pina M Cardarelli, Ph.D., Irene M. Ghobrial, MD
Journal: Blood
Blood (2011) 118 (21): 1844.
https://doi.org/10.1182/blood.V118.21.1844.1844
Published: 2011